| Touchworks Chiropractic, P.a. | |
|
1629 W Main St Albert Lea MN 56007-1868 | |
| (507) 373-1940 | |
| Not Available |
| Full Name | Touchworks Chiropractic, P.a. |
|---|---|
| Speciality | Clinic/Center |
| Location | 1629 W Main St, Albert Lea, Minnesota |
| Authorized Official Name and Position | Alison Sorensen (OWNER) |
| Authorized Official Contact | 5073831906 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Touchworks Chiropractic, P.a. 66090 200th St Alden MN 56009-5516 Ph: (507) 383-1906 | Touchworks Chiropractic, P.a. 1629 W Main St Albert Lea MN 56007-1868 Ph: (507) 373-1940 |
| NPI Number | 1194998807 |
|---|---|
| Provider Enumeration Date | 04/02/2008 |
| Last Update Date | 07/17/2008 |
| Medicare PECOS PAC ID | 2062581127 |
|---|---|
| Medicare Enrollment ID | O20080515000665 |
News Archive
Results of a new study confirm trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States, than they do if they live in their homelands.
Zika virus. Ebola virus. Influenza. SARS and MERS corona viruses. Existing and emerging viral diseases are an increasing problem, particularly in developing countries. The World Health Organization has called for better control of viral diseases, but developing drugs for this purpose can be challenging.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.
At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually pose no risk to health (self-antigens).
ISTA Pharmaceuticals, Inc., today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194998807 | NPI | - | NPPES |
| C04903 | Other | MN | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 5106 (Minnesota) | Primary |
| Provider Name | Alison A Sorensen |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1801068549 PECOS PAC ID: 2163591223 Enrollment ID: I20080515000657 |
News Archive
Results of a new study confirm trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States, than they do if they live in their homelands.
Zika virus. Ebola virus. Influenza. SARS and MERS corona viruses. Existing and emerging viral diseases are an increasing problem, particularly in developing countries. The World Health Organization has called for better control of viral diseases, but developing drugs for this purpose can be challenging.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.
At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually pose no risk to health (self-antigens).
ISTA Pharmaceuticals, Inc., today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.
› Verified 1 days ago
News Archive
Results of a new study confirm trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States, than they do if they live in their homelands.
Zika virus. Ebola virus. Influenza. SARS and MERS corona viruses. Existing and emerging viral diseases are an increasing problem, particularly in developing countries. The World Health Organization has called for better control of viral diseases, but developing drugs for this purpose can be challenging.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin, is highlighted in a paper published in the scientific journal Human Vaccines.
At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually pose no risk to health (self-antigens).
ISTA Pharmaceuticals, Inc., today announced the Company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for bromfenac ophthalmic solution dosed once-daily as a treatment for ocular inflammation and pain following cataract surgery.
› Verified 1 days ago
Patient's Choice Wellness Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 904 1/2 E Plaza St, Albert Lea, MN 56007 Phone: 507-821-1051 | |
Mercyone Albert Lea Family Medicine & Specialty Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2440 Bridge Ave, Albert Lea, MN 56007 Phone: 507-473-2249 Fax: 507-473-2088 | |
Mayo Clinic Health System-southeast Minnesota Region Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 404 W Fountain St, Albert Lea, MN 56007 Phone: 507-373-2384 |